Key Laboratory of Forest Plant Ecology, Ministry of Education, Northeast Forestry University, Harbin 150040, PR China.
J Theor Biol. 2010 Dec 7;267(3):363-74. doi: 10.1016/j.jtbi.2010.08.029. Epub 2010 Sep 8.
Docking and molecular dynamics were used to study the nine ligands (see Scheme 1) at the neuraminidase (NA) active sites. Their binding modes are structurally and energetically different, with details given in the text. Compared with 1A (oseltamivir carboxylate), the changes of core template or/and functional groups in the other ligands cause the reductions of interaction energies and numbers of H-bonds with the NA proteins. Nonetheless, all these ligands occupy the proximity space at the NA active sites and share some commonness in their binding modes. The fragment approach was then used to analyze and understand the binding specificities of the nine ligands. The contributions of each core template and functional group were evaluated. It was found that the core templates rather than functional groups play a larger role during the binding processes; in addition, the binding qualities are determined by the synergistic effects of the core templates and functional groups. Among the nine ligands, 1A (oseltamivir carboxylate) has the largest synergistic energy and its functional groups fit perfectly with the NA active site, consistent with the largest interaction energy, numerous H-bonds with the NA active-site residues as well as experimentally lowest IC(50) value. Owing to the poorer metabolizability than oseltamivir, large contribution of the benzene core template and fine synergistic effects of the functional groups, the 4-(N-acetylamino)-5-guanidino-3-(3-pentyloxy)benzoic acid should be an ideal lead compound for optimizing NA drugs.
对接和分子动力学被用于研究神经氨酸酶(NA)活性部位的 9 种配体(见图 1)。它们的结合模式在结构和能量上都不同,详细信息见正文。与 1A(奥司他韦羧酸)相比,其他配体的核心模板或/和功能基团的变化导致与 NA 蛋白的相互作用能和氢键数量减少。尽管如此,所有这些配体都占据了 NA 活性部位的临近空间,并且在结合模式上具有一些共同性。然后采用片段方法来分析和理解 9 种配体的结合特异性。评估了每个核心模板和功能基团的贡献。结果发现,在结合过程中核心模板比功能基团起着更大的作用;此外,结合质量由核心模板和功能基团的协同效应决定。在这 9 种配体中,1A(奥司他韦羧酸)具有最大的协同能量,其功能基团与 NA 活性部位完美匹配,这与最大的相互作用能、与 NA 活性部位残基的大量氢键以及实验上最低的 IC50 值一致。由于代谢性不如奥司他韦,苯核心模板的贡献较大,功能基团的协同效应较好,4-(N-乙酰氨基)-5-胍基-3-(3-戊氧基)苯甲酸应该是优化 NA 药物的理想先导化合物。